Based in Freiburg, Germany, Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce supreme biologics like antibodies, replacement enzymes, or fusion toxins. Eleva has successfully developed drug candidates into clinical phases.
Impressum: https://www.elevabiologics.com/contact/imprint/
Location: Germany, Baden-Württemberg, Freiburg im Breisgau
Employees: 11-50
Total raised: $74.03M
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | D11Z.Ventu... | d11z.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.01.2021 | - | $74.03M | - |
Mentions in press and media 5
| Date | Title | Description |
| 16.04.2024 | Molecular farming startup Nobell Foods rebrands as Alpine Bio, secures 10th US patent | [Disclosure: AgFunderNews’ parent company AgFunder is an investor in Alpine Bio.] Nobell Foods—a molecular farming startup engineering plants to produce animal proteins in what it claims is a more sustainable and ultimately more efficient m... |
| 02.04.2024 | Casein… from potatoes? Molecular farming startup Finally Foods emerges from stealth | Finally Foods—an Israeli molecular farming startup producing dairy proteins in potatoes—has emerged from stealth with pre-seed funding from The Kitchen FoodTech Hub (TKH) by Strauss Group and the Israeli Innovation Authority. Founded by Dr.... |
| 12.10.2021 | Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins | FREIBURG, Germany, Oct. 12, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical part... |
| 14.09.2021 | Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H | FREIBURG, Germany, Sept. 14, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three cli... |
| 06.01.2021 | Eleva Secures Up To €60M in Funding | Eleva, a Freiburg, Germany-based manufacturer of superior biologics, secured up to €60m in funding. Zukunftsfonds Heilbronn (ZFHN) provided the capital Eleva leverages its moss-based production platform to produce supreme biologics like ant... |